Joint Corp
NASDAQ:JYNT

Watchlist Manager
Joint Corp Logo
Joint Corp
NASDAQ:JYNT
Watchlist
Price: 8.61 USD -4.12% Market Closed
Market Cap: 128m USD

Joint Corp
Investor Relations

The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. The company is headquartered in Scottsdale, Arizona and currently employs 316 full-time employees. The company went IPO on 2014-11-11. Its segments include Corporate Clinics and Franchise Operations. Corporate Clinics segment is comprised of the operating activities of the Company-owned or managed clinics. The firm operates or manages approximately 96 clinics under this segment. Franchise Operations segment is comprised of the operating activities of the franchise business unit. The franchise system consists of approximately 610 clinics in operation. The company offers a range of membership and wellness packages. The company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 6, 2025
AI Summary
Q3 2025

Revenue Growth: Revenue rose 6% year-over-year to $13.4 million, mainly due to more franchise clinics.

Profitability: Adjusted EBITDA improved 36%, reflecting cost reductions and operational improvements.

Comps & Sales: System-wide sales fell 1.5% and same-store sales (comps) declined 2%, prompting a cut to full-year sales guidance.

Guidance Revision: Full-year 2025 system-wide sales and comp sales guidance were lowered; adjusted EBITDA and new clinic opening guidance remain unchanged.

Franchising Shift: Progress continues toward becoming a 100% franchisor, with an agreement to sell 45 corporate clinics and negotiations ongoing for 33 more.

Marketing Strategy: Shifted marketing focus to pain relief and launched a national campaign, reallocating local ad spend nationally.

Pricing Plan: Testing price increases on recurring plans with three pilot tiers across 200 clinics, with a broader rollout planned for Q1 2026 if successful.

Technology Investments: Launched a new patient app, seeing strong early adoption and positive patient feedback.

Key Financials
Revenue
$13.4 million
System-wide Sales
$127 million
Comp Sales
-2%
Adjusted EBITDA (Consolidated Operations)
$3.3 million
Adjusted EBITDA (Continuing Operations)
$1.4 million
Net Income (Consolidated)
$855,000
Net Income (Continuing Operations)
$290,000
Diluted EPS (Continuing Operations)
$0.02
Unrestricted Cash & Equivalents
$29.7 million
Clinic Openings (Q3)
9 franchise clinics opened, 11 closed
Franchise Licenses Sold (Q3)
8
Franchised Clinics (as of September 30)
884
Clinic App Downloads
178,000
App Adoption (New Patients)
18%
Stock Repurchases (Q3)
228,000 shares for $2.3 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Jake Singleton CPA
Chief Financial Officer
No Bio Available
Mr. Sanjiv Razdan
CEO, President & Director
No Bio Available
Mr. Jorge Armenteros
Senior Vice President of Operations
No Bio Available
Mr. Charles Nelles
Chief Technology Officer
No Bio Available
Dr. Steven Knauf
Vice President of Chiropractic & Compliance
No Bio Available
Ms. Lori I. Abou Habib
Chief Marketing Officer
No Bio Available
Ms. Beth Gross
Senior Vice President of Human Resources
No Bio Available
Mr. Eric Simon
Senior Vice President of Franchise Sales & Development
No Bio Available
Mr. Craig P. Colmar J.D.
Secretary
No Bio Available

Contacts

Address
ARIZONA
Scottsdale
16767 N Perimeter Drive, Suite 110
Contacts
+14802455960.0
www.thejoint.com